Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Circulating Tumor Cells Market?

The market size for circulating tumor cells has seen a swift expansion in recent times. It is predicted to rise from $11.9 billion in 2024 to approximately $13.37 billion in 2025, with a compound annual growth rate (CAGR) of 12.4%. The notable growth during the historic period can be associated with factors such as the rise in cancer cases, the usefulness of clinical staging in cancer treatments, the introduction of liquid biopsies, preference by patients for less invasive tests, regulatory backing for liquid biopsies, and a concentrated effort towards early cancer detection.

What Growth Rate Is Forecasted for the Circulating Tumor Cells Market by 2029?

Expectations predict a swift expansion in the circulating tumor cells market in the upcoming years. The market is projected to escalate to $21.68 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 12.8%. The considerable growth in the forecast period is linked to point-of-care CTC testing, the use of microfluidics, emphasis on rare cancer types, standardization of CTC assays, increase in CTC-based clinical trials, and economic growth in emergent markets. Key trends during this period consist of innovative approaches in CTC isolation, government-sponsored funding for CTC research, progress in CTC detection technologies, the application of liquid biopsy for cancer surveillance, integration with single-cell analysis, and the merging of technology with artificial intelligence (AI).

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8950&type=smp

Which Key Companies Are Shaping the Future of the Circulating Tumor Cells Market?

Major companies operating in the circulating tumor cells market include Precision Medicine Group LLC, Bio-Techne Corporation, BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., Qiagen N.V., ScreenCell SAS, STEMCELL Technologies Inc., Sysmex Corporation, Aviva Biosciences Corporation, LungLife AI Inc., Miltenyi Biotec GmbH, Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, LineaRx Inc., Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Stanford Research Institute International, Agilent Technologies Inc., Resolution Bioscience Inc., Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd.

Which Factors Are Driving Demand in the Circulating Tumor Cells Industry?

The escalating prevalence of cancer is anticipated to fuel the expansion of the circulating tumor cells market. Cancer is a condition where certain cells in the body grow without control, spreading to other areas. Circulating tumor cells play a crucial role in early cancer detection and diagnosis; thus, their demand increases with the rising prevalence of cancer. To illustrate, the American Cancer Society Journals, a humanitarian health organization from the US, predicted in January 2023 that around 1,958,310 new instances of cancer would be identified, potentially leading to 609,820 deaths related to cancer in the United States. Hence, the increasing prevalence of cancer is a significant propelling factor for the circulating tumor cells market’s growth.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8950&type=smp

How Is the Circulating Tumor Cells Market Segmented by Several Divisions?

The circulating tumor cells market covered in this report is segmented –

1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems

2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis

3) By Specimen: Blood, Bone Marrow, Other Body Fluids

4) By Application: Clinical Or Liquid Biopsy, Research

Subsegments:

1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits

2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes

3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems

What are the Emerging Market Trends Driving the Growth of the Circulating Tumor Cells Industry?

Innovative product development is emerging as a main trend in the circulating tumor cells industry. Significant players in this market are investing in the creation of groundbreaking products to cement their market standing. For illustration, Bio-Rad Laboratories, Inc., a medical laboratory based in the United States, kickstarted this trend in June 2024 by launching Celselect Slides 2.0. This product is engineered to optimize the capture of uncommon cells and circulating tumor cells (CTCs), thus boosting precision and productivity in cell analysis for clinical and research purposes.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report

Which Regions Are Driving Growth in the Circulating Tumor Cells Market?

North America was the largest region in the circulating tumor cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8950

This Report Delivers Insight On:

1. How big is the circulating tumor cells market, and how is it changing globally?

2. Who are the major companies in the circulating tumor cells market, and how are they performing?

3. What are the key opportunities and risks in the circulating tumor cells market right now?

4. Which products or customer segments are growing the most in the circulating tumor cells market?

5. What factors are helping or slowing down the growth of the circulating tumor cells market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model